{"id":"W1976338840","doi":"10.1016/j.pupt.2011.10.002","title":"Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension","year":2011,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Actelion Pharmaceuticals; Bayer Canada; United Therapeutics Corporation; Pfizer","keywords":"Medicine; Placebo; Peripheral edema; Adverse effect; Nausea; Clinical endpoint; Anesthesia; Internal medicine; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006689857,0.0004579725,0.001570981,0.0002866026,0.0002721876,0.000399412,0.0002978176,0.0006568863,0.001637986],"category_scores_gemma":[0.00143924,0.0002620207,0.0009109005,0.0002924649,0.0004608628,0.0006789151,0.0001793858,0.00148771,0.0003833384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003335458,"about_ca_system_score_gemma":0.0005899218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000574443,"about_ca_topic_score_gemma":0.0010715,"domain_scores_codex":[0.9996616,0.0001342869,0.00004703917,0.00004910204,0.00005913744,0.0000488352],"domain_scores_gemma":[0.9993191,0.0002746981,0.0001288392,0.00005504392,0.00004324012,0.0001790222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7310951,0.007349194,0.08607543,0.0004758918,0.001673473,0.001095109,0.0002894538,0.002396893,0.04876737,0.0002455115,0.0009403022,0.1195963],"study_design_scores_gemma":[0.1385531,0.2700092,0.5652702,0.0001203488,0.002546492,0.001819794,0.0004310159,0.005361835,0.01186644,0.0005756535,0.003322251,0.0001238021],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965087,0.001854914,0.0001114858,0.0001847582,0.00003948443,0.00004203368,0.0001953813,0.00002358137,0.00103976],"genre_scores_gemma":[0.9982975,0.0007180639,0.0001144057,0.0001732777,0.00006563798,0.0000303677,0.0002558628,0.000003905608,0.0003409966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001637986,"threshold_uncertainty_score":0.005479634,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03833353606268927,"score_gpt":0.288309320125465,"score_spread":0.2499757840627757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}